Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis

Gastrointestinal Endoscopy

Volumn 59, Issue 3, 2004, Pages 333-338

  Lo, Gin Ho ^a,b   Chen, Wen Chi ^a,b   Chen, Mei Hsiu ^a,b   Lin, Chi Pin ^a,b   Lo, Ching Chu ^a,b   Hsu, Ping I ^a,b   Cheng, Jin Shiung ^a,b   Lai, Kwok Hung ^a,b  

^a National Yang Ming University ^*

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; LACTULOSE; NADOLOL; SCOPOLAMINE BUTYL BROMIDE; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DYSPHAGIA; DYSPNEA; ECHOGRAPHY; ENDOSCOPIC THERAPY; ENDOSCOPIC VARICEAL LIGATION; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; IMPOTENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RETROSTERNAL PAIN; SAFETY; UPPER GASTROINTESTINAL BLEEDING; VEIN LIGATION;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NADOLOL; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1542619403     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)02819-0     Document Type: Article

References (30)

1. Lake JR, Howdle PD. Gastrointestinal hemorrhage and portal hypertension. In: O'Grady JG, Lake JR, Howdle PD, editors. Comprehensive hepatology. London: Mosby; 2000. p. 1-13.
2. Infante-Rivard C, Esnaola S, Villeneuve JP. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology 1989; 96:1087-92.
3. Pagliaro L, D'Amico G, Sorensen TI, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992;117:59-70.
4. Schuman M, Beckman JW, Tedesco FJ, Griffin JW Jr, Assad T. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 1987;82:823-30.
5. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a metaanalysis. Ann Intern Med 1995;123:280-7.
6. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527-32.
7. Gimson AES, Ramage K, Panos MZ, Hayllar K, Harrison PM, Williams R, et al. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices. Lancet 1993;342:391-4.
8. Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995;22:466-71.
9. de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 1999;19:439-55.
10. Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, Wu KL, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997;25:1346-50.
11. Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol 1999;31:451-6.
12. De BK, Ghoshal UC, Das T, Santra A, Biswas PK. Endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999;14:220-4.
13. Sarin SK, Lamba G, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988-93.
14. Burroughs AK, Patch D. Primary prevention of bleeding from esophageal varices. N Engl J Med 1999;340:1033-5.
15. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001;345:669-81.
16. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-48.
17. Lebrec D. Primary prevention variceal bleeding. What's new? Hepatology 2001;33:1003-4.
18. Boyer TD. Pharmacologic treatment of portal hypertension: past, present, and future. Hepatology 2001;34:834-9.
19. Pugh RNN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
20. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-8.
21. Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997;112:473-82.
22. Abraczinskas DR, Ookubo R, Grace ND, Groszmann RJ, Bosch J, Garcia-Tsao G, et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment? Hepatology 2001;34:1096-102.
23. Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology 1987; 7:648-53.
24. Lebrec D, Bernuau J, Rueff B, Benhamou JP. Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis. N Engl J Med 1982;307:560.
25. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001;33:802-7.
26. Pagliaro L. Milestones in liver disease. J Hepatol 2002; 36:148-50.
27. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1988;319:983-9.
28. Lo GH, Liang HL, Lai KH, Chang CF, Hwu JH, Chen SM, et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system. J Hepatol 1996;24:74-80.
29. Lo GH, Lai KH, Cheng JS, Hsu PI, Chen TA, Wang EM, et al. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. Gastrointest Endosc 2001;53:579-84.
30. Lo GH, Chen WC, Chen MH, Hsu PI, Lin CK, Tsai WL, et al. A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002;123:728-34.